We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Advice on Drug Master Files for CDER-Led Combination Products
FDA Offers Advice on Drug Master Files for CDER-Led Combination Products
Sponsors of CDER-led drug-device combination products that include electronics or software should include specific technical information in their Type V drug master files, the FDA said in a draft guidance released on Monday.